4
Changes in Ownership
Foghorn Therapeutics Inc. Filed Acc 0001562180-23-006837
Options or other derivatives
- Chief Medical Officer acquired 272,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Cardama Alfonso Quintas Chief Medical Officer | 2023-09-11 | Grant or award · Stock Options (Right to buy) | +272,000 | $7.57 | $2,059,040 | 272,000 | D |
Loading xslF345X05/primarydocument.xml…